TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17367312

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg/day for 8 weeks followed by 20 mg/day for a further 8 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Atorvastatin 10 mg/day for 8 weeks followed by 20 mg/day for a further 8 weeks
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Atorvastatin
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Rosuvastatin and Atorvastatin
Number of subjects: 100
Study: 15539727

Group type: EXPERIMENTAL
Intervention: Intrapericardial Blake drain
Number of subjects: 202

Group type: COMPARATOR
Intervention: Intrapericardial semirigid drain
Number of subjects: 202
Study: 11449026

Group type: EXPERIMENTAL
Intervention: active rTMS
Number of subjects: 33

Group type: COMPARATOR
Intervention: sham rTMS
Number of subjects: 33
Study: 9684123

Group type: COMPARATOR
Intervention: Ad libitum fluid intake (Group 1)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: 2 liters of mineral water per day (Group 2)
Number of subjects: 117
Study: 7922450

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) administration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Growth factors in combination with specialized nutrition
Number of subjects: 0
Study: 3149548

Group type: EXPERIMENTAL
Intervention: Adenosine (various doses, intra-arterial)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Glyceryl trinitrate (1 to 20 micrograms, intra-arterial)
Number of subjects: 8
Study: 31822477

Group type: EXPERIMENTAL
Intervention: iSPRINT NMT warm-up (15 min, including aerobic, agility, strength, and balance exercises)
Number of subjects: 1067

Group type: EXPERIMENTAL
Intervention: iSPRINT NMT warm-up
Number of subjects: 1067

Group type: COMPARATOR
Intervention: Standard-of-practice warm-up
Number of subjects: 1067
Study: 29359313

Group type: EXPERIMENTAL
Intervention: Combined supraclavicular and PECS II block (Group PECS)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Combined supraclavicular and sham block (Group SCB)
Number of subjects: 36
Study: 28455199

Group type: EXPERIMENTAL
Intervention: Upper Body Compression Garment (UBCG)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 20
Study: 26576946

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: Blended Motivational Interviewing and Problem Solving Therapy (MI-PST)
Number of subjects: 335

Group type: COMPARATOR
Intervention: Psycho-educational Control Group (CG)
Number of subjects: 335
Study: 23990896

Group type: EXPERIMENTAL
Intervention: moodManager + TeleCoach
Number of subjects: 101

Group type: COMPARATOR
Intervention: self-directed moodManager
Number of subjects: 101

Group type: COMPARATOR
Intervention: waitlist control (WLC)
Number of subjects: 101
Study: 21039351

Group type: EXPERIMENTAL
Intervention: Propofol at target effect-site concentrations of 2.0, 2.5, 3.0, 3.5, and 4.0 microg/ml during TCI with sufentanil (0.2 ng/ml)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Propofol at target effect-site concentrations
Number of subjects: 160
Study: 19925662

Group type: EXPERIMENTAL
Intervention: Reflux Disease Questionnaire (RDQ)
Number of subjects: 18000

Group type: EXPERIMENTAL
Intervention: Modified Rome II questionnaire
Number of subjects: 18000

Group type: EXPERIMENTAL
Intervention: Epworth Sleepiness Scale (ESS)
Number of subjects: 18000

Group type: EXPERIMENTAL
Intervention: 36-item Short Form Health Survey (SF-36)
Number of subjects: 18000

Group type: EXPERIMENTAL
Intervention: Endoscopy
Number of subjects: 18000
Study: 17133564

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) 2 to 3 g/day with reduced CNI dose (≥50% of initial dose)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no MMF, CNI dose not reduced below 75% of initial dose)
Number of subjects: 56
Study: 12960821

Group type: EXPERIMENTAL
Intervention: d4T/ddI
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: ZDV/3TC
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: ZDV/3TC/ddI
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Switch from d4T/ddI to ZDV/3TC
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Switch from ZDV/3TC to d4T/ddI
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Switch from ZDV/3TC/ddI to d4T/3TC/abacavir
Number of subjects: 21
Study: 11050639

Group type: EXPERIMENTAL
Intervention: Ferric ammonium citrate (FAC)
Number of subjects: 203
Study: 9350071

Group type: EXPERIMENTAL
Intervention: Smoking cessation (quitting immediately)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Continued smoking (control group)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Successful quitters (after 26 weeks)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Unsuccessful quitters (after 26 weeks)
Number of subjects: 182
Study: 1279468

Group type: EXPERIMENTAL
Intervention: Ranitidine (50 mg 4 times a day e.v.)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No anti H2 treatment (Control)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 40
Study: 3769898

Group type: EXPERIMENTAL
Intervention: 100 mg meptazinol i.m.
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 10 mg morphine i.m.
Number of subjects: 24

Group type: COMPARATOR
Intervention: saline (control)
Number of subjects: 24
Study: 28699054

Group type: EXPERIMENTAL
Intervention: Behavioral couples therapy (BCT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Individual cognitive behavioral therapy (CBT)
Number of subjects: 36
Study: 26482543

Group type: EXPERIMENTAL
Intervention: Doxepin hydrochloride (6 mg) in tomato juice
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (tomato juice)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both Doxepin and Placebo
Number of subjects: 20
Study: 24728774

Group type: EXPERIMENTAL
Intervention: Opportunistic screening (pulse and ECG)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Systematic screening (postal invitation for ECG)
Number of subjects: 200
Study: 22200728

Group type: EXPERIMENTAL
Intervention: Bosentan, 125 mg two times per day, n = 28
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo, n = 28
Number of subjects: 46
Study: 20659956

Group type: EXPERIMENTAL
Intervention: Alemtuzumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interferon β‐1a
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conditioned media from post‐alemtuzumab peripheral blood mononuclear cell cultures
Number of subjects: 0
Study: 18568482

Group type: EXPERIMENTAL
Intervention: Axitinib (administered orally twice daily until disease progression or intolerance)
Number of subjects: 52
Study: 15752950

Group type: EXPERIMENTAL
Intervention: 5 mg/d of oral folic acid for 4 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo for 4 weeks
Number of subjects: 26
Study: 12030913

Group type: EXPERIMENTAL
Intervention: Breast milk (mean intake 84%)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Formula milk (less than 25% breast milk, mean intake 3.3%)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Breast milk
Number of subjects: 57

Group type: COMPARATOR
Intervention: Formula milk
Number of subjects: 57
Study: 10342484

Group type: EXPERIMENTAL
Intervention: Therapeutic massage sessions of 10 minutes per day in combination with treatment with pressure garments
Number of subjects: 30

Group type: COMPARATOR
Intervention: Pressure garments alone
Number of subjects: 30
Study: 8595539

Group type: EXPERIMENTAL
Intervention: Azelastine nasal spray, 2 sprays/nostril bid
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Azelastine nasal spray, 2 sprays/nostril qd
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Oral chlorpheniramine maleate, 12 mg bid
Number of subjects: 264

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 264
Study: 1790542

Group type: EXPERIMENTAL
Intervention: Nitrendipine (10 mg twice daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Diltiazem (60 mg thrice daily)
Number of subjects: 30
Study: 6111632

Group type: EXPERIMENTAL
Intervention: Propranolol (60‐120 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 30049524

Group type: EXPERIMENTAL
Intervention: Sevoflurane OLV
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Desflurane OLV
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both OLV groups
Number of subjects: 24
Study: 28453849

Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART) with initial efavirenz
Number of subjects: 1016

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1016
Study: 25784719

Group type: COMPARATOR
Intervention: CDP7657 IV (0.004-5 mg/kg)
Number of subjects: 45

Group type: COMPARATOR
Intervention: CDP7657 IV (5-60 mg/kg)
Number of subjects: 45

Group type: COMPARATOR
Intervention: CDP7657
Number of subjects: 45
Study: 23932756

Group type: EXPERIMENTAL
Intervention: Communication training intervention (5As: Ask, Advise, Agree, Assist, Arrange)
Number of subjects: 326

Group type: COMPARATOR
Intervention: Control group (delayed communication training, 8 months later)
Number of subjects: 326
Study: 21112668

Group type: EXPERIMENTAL
Intervention: eDerm online curriculum after clerkship
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: eDerm online curriculum
Number of subjects: 252

Group type: COMPARATOR
Intervention: Clerkship
Number of subjects: 252
Study: 19733859

Group type: EXPERIMENTAL
Intervention: Apical pacing
Number of subjects: 19

Group type: COMPARATOR
Intervention: Septal pacing
Number of subjects: 19
Study: 16759322

Group type: EXPERIMENTAL
Intervention: Articaine 4% with 1 : 200 000 epinephrine
Number of subjects: 62

Group type: COMPARATOR
Intervention: Lidocaine 2% with 1 : 100 000 epinephrine
Number of subjects: 62
Study: 15223191

Group type: EXPERIMENTAL
Intervention: Bilateral prefrontal leukotomy (LSP)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Non-leukotomized schizophrenia patients (NLSP)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 12
Study: 12501898

Group type: EXPERIMENTAL
Intervention: Misoprostol (1-11 tablets, vaginal route)
Number of subjects: 103
Study: 9831367

Group type: EXPERIMENTAL
Intervention: IFN-alpha + Talpha1 (1 mg twice weekly)
Number of subjects: 34

Group type: COMPARATOR
Intervention: IFN-alpha alone (3 million units three times a week)
Number of subjects: 34
Study: 7716590

Group type: EXPERIMENTAL
Intervention: Meropenem 500 mg every 8 hours
Number of subjects: 377

Group type: COMPARATOR
Intervention: Imipenem/cilastatin 500 mg every 6 hours
Number of subjects: 377
Study: 2758765

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Collagen
Number of subjects: 0

Group type: COMPARATOR
Intervention: PAF
Number of subjects: 0
Study: 788079

Group type: EXPERIMENTAL
Intervention: Intravenous plasminogen
Number of subjects: 500

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 500
Study: 30884961

Group type: EXPERIMENTAL
Intervention: Telephone-based cognitive behavioral therapy (CBT)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: In-person cognitive behavioral therapy (CBT)
Number of subjects: 109
Study: 31102382

Group type: EXPERIMENTAL
Intervention: Polyethylene Glycol (PEG) for 12 weeks
Number of subjects: 102

Group type: COMPARATOR
Intervention: Lactulose for 12 weeks
Number of subjects: 102

Group type: COMPARATOR
Intervention: Lactulose
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Polyethylene Glycol (PEG)
Number of subjects: 102
Study: 27900529

Group type: EXPERIMENTAL
Intervention: Prior enamel etch + ER adhesive (XP Bond)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Prior enamel etch + SE adhesive (Clearfil SE Bond)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Conventional acid-etch sealant (control group)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: SE adhesive (Clearfil SE Bond) without prior etching
Number of subjects: 57
Study: 25367184

Group type: EXPERIMENTAL
Intervention: Limberg flap (n=51)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Excision only (n=51)
Number of subjects: 102
Study: 23902780

Group type: EXPERIMENTAL
Intervention: Traditional Mediterranean diet supplemented with virgin olive oil (TMD+VOO)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Traditional Mediterranean diet supplemented with nuts (TMD+Nuts)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Low-fat diet (Control)
Number of subjects: 34
Study: 21666588

Group type: EXPERIMENTAL
Intervention: Cytoflavin, 2 ml/kg/day, intravenously for 5 days
Number of subjects: 120

Group type: COMPARATOR
Intervention: Basic treatment without cytoflavin
Number of subjects: 120
Study: 19299322

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba 120 mg twice daily for 12 days
Number of subjects: 14

Group type: COMPARATOR
Intervention: Voriconazole 200 mg alone
Number of subjects: 14
Study: 16886840

Group type: EXPERIMENTAL
Intervention: Folic acid (10mg/day for 2 weeks)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 15337631

Group type: EXPERIMENTAL
Intervention: Verum acupuncture
Number of subjects: 452

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 452
Study: 11565630

Group type: EXPERIMENTAL
Intervention: Pagoclone 0.1 mg t.d.s.
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 9137213

Group type: EXPERIMENTAL
Intervention: Amiodarone, 300 mg/day
Number of subjects: 516

Group type: COMPARATOR
Intervention: Nonantiarrhythmic therapy
Number of subjects: 516
Study: 8205301

Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 3251503

Group type: EXPERIMENTAL
Intervention: Triazolam 0.125 mg
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Triazolam 0.25 mg
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Triazolam 0.50 mg
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 30818782

Group type: EXPERIMENTAL
Intervention: 80 mg/day iron (800 mg of iron protein succinylate)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 18
Study: 27864718

Group type: EXPERIMENTAL
Intervention: 32 NaP tablets
Number of subjects: 461

Group type: COMPARATOR
Intervention: 4 L of PEG
Number of subjects: 461
Study: 25264121

Group type: EXPERIMENTAL
Intervention: Serum-based medium
Number of subjects: 7

Group type: COMPARATOR
Intervention: Synthetic medium
Number of subjects: 7
Study: 23727761

Group type: EXPERIMENTAL
Intervention: Dance/movement therapy
Number of subjects: 115
Study: 21252253

Group type: EXPERIMENTAL
Intervention: 1.4 g/kg fructose in divided oral doses over 6 h (protocol 1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 0.5 g/kg fructose, 0.5 g/kg fructose plus 0.5 g/kg glucose, or 1 g/kg fructose plus 1 g/kg glucose (protocol 2)
Number of subjects: 30
Study: 19149838

Group type: EXPERIMENTAL
Intervention: Water-based exercise (WE)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Walking on land (WL)
Number of subjects: 50
Study: 16936102

Group type: EXPERIMENTAL
Intervention: Mean Prognosis (MP) index
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intraocular pressure (IOP) asymmetry
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Threshold asymmetry between eyes
Number of subjects: 0
Study: 12805326

Group type: EXPERIMENTAL
Intervention: Tamoxifen for 5 years (n = 943)
Number of subjects: 1901

Group type: COMPARATOR
Intervention: Tamoxifen for 2 years (n = 958)
Number of subjects: 1901

Group type: EXPERIMENTAL
Intervention: Tamoxifen for 5 years (n = 943) in ER-positive patients
Number of subjects: 1901
Study: 11015108

Group type: EXPERIMENTAL
Intervention: Bladder-drainage with induction immunotherapy
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Enteric-drainage with induction immunotherapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Enteric-drainage without induction immunotherapy
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Bladder-drainage
Number of subjects: 100

Group type: COMPARATOR
Intervention: Enteric-drainage
Number of subjects: 100
Study: 8851402

Group type: EXPERIMENTAL
Intervention: MR imaging
Number of subjects: 75

Group type: COMPARATOR
Intervention: Sonography
Number of subjects: 75
Study: 1508401

Group type: EXPERIMENTAL
Intervention: ACSF with 50 mM K+ (depolarization)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: ACSF with 50 mM K+, 0 mM Ca2+ and 4 mM Mg2+ (depolarization during blocked synaptic transmission)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Regular ACSF (control)
Number of subjects: 8
Study: 6323338

Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 33

Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 33
Study: 30289769

Group type: EXPERIMENTAL
Intervention: Continuous video EEG monitoring and real-time seizure detection
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Automated neonatal seizure detector algorithm by Persyst
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: EEG technician review by Corticare
Number of subjects: 260
Study: 29513852

Group type: EXPERIMENTAL
Intervention: Bacille Calmette-Guérin (BCG) revaccination
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 26997110

Group type: EXPERIMENTAL
Intervention: Phone completion of the SRS‐22r
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Phone completion of the ODI
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Phone administration preference
Number of subjects: 49
Study: 24993757

Group type: EXPERIMENTAL
Intervention: disconnect‐reconnect technique
Number of subjects: 16

Group type: COMPARATOR
Intervention: push‐pull technique
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: both techniques
Number of subjects: 16
Study: 22443183

Group type: EXPERIMENTAL
Intervention: Sitagliptin (100 mg daily)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Insulin dose increase (≥ 10% at week 12 and ≥ 10% at week 24)
Number of subjects: 140
Study: 20139217

Group type: EXPERIMENTAL
Intervention: Delayed use of antibiotics
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Antibiotic delay strategy
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Lifestyle habits and behaviours
Number of subjects: 21
Study: 17911711

Group type: EXPERIMENTAL
Intervention: Surveillance system for chronic diseases (intervention group)
Number of subjects: 865

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 865
Study: 11333850

Group type: EXPERIMENTAL
Intervention: Beta-carotene dissolved in oil (80 microg per capsule) consumed 2 capsules/day, 7 days/week for up to 10 weeks
Number of subjects: 35
Study: 9407423

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 89

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 89
Study: 8501186

Group type: EXPERIMENTAL
Intervention: Homologous intra-uterine insemination with ovulation induction
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Timed natural intercourse with ovulation induction
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (timed homologous intravaginal artificial insemination)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Overall outcomes of pregnancies in the ovulation induced group
Number of subjects: 84
Study: 2894890

Group type: EXPERIMENTAL
Intervention: Enalapril 10 to 40 mg once daily
Number of subjects: 180

Group type: COMPARATOR
Intervention: Atenolol 50 to 100 mg once daily
Number of subjects: 180
Study: 30239426

Group type: EXPERIMENTAL
Intervention: Dapivirine vaginal ring
Number of subjects: 2629
Study: 28705697

Group type: EXPERIMENTAL
Intervention: Stepping Up intervention group
Number of subjects: 266

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 266
Study: 25832289

Group type: EXPERIMENTAL
Intervention: Preoperative rosuvastatin
Number of subjects: 550

Group type: COMPARATOR
Intervention: Control (no preoperative rosuvastatin)
Number of subjects: 550
Study: 24284249

Group type: EXPERIMENTAL
Intervention: Parecoxib sodium 20/40 mg administered via intravenous injection after admission with 12 hours intervals for six times
Number of subjects: 80

Group type: COMPARATOR
Intervention: Morphine 2/4 mg initially, additional morphine 2 mg as needed
Number of subjects: 80
Study: 20608798

Group type: EXPERIMENTAL
Intervention: Music during non-stress test (NST)
Number of subjects: 201

Group type: COMPARATOR
Intervention: No music during non-stress test (NST)
Number of subjects: 201
Study: 18297254

Group type: EXPERIMENTAL
Intervention: cilazapril (5 mg)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: atenolol (50 mg)
Number of subjects: 38
Study: 17139640

Group type: EXPERIMENTAL
Intervention: Internet‐based physical activity program with individual guidance, a bicycle ergometer, and group contacts (individualized training [IT] group; n = 82)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Internet‐based program providing only general information on exercises and physical activity (general training [GT] group; n = 78)
Number of subjects: 160
Study: 12681027

Group type: EXPERIMENTAL
Intervention: Orlistat 120 mg three times daily
Number of subjects: 376

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 376
Study: 10924972

Group type: EXPERIMENTAL
Intervention: Accelerated fractionation (AF) of 30 Gy in 10 daily fractions
Number of subjects: 445

Group type: COMPARATOR
Intervention: Accelerated hyperfractionated (AH) radiotherapy (1.6 Gy b.i.d. to a total dose of 54.4 Gy)
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: MMSE improvement over time
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: Baseline MMSE
Number of subjects: 445
Study: 8953351

Group type: EXPERIMENTAL
Intervention: Qualitative data collection regarding experiences of chronic pain
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Belief and validation of pain by others
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Support from health care professionals
Number of subjects: 75
Study: 1423948

Group type: EXPERIMENTAL
Intervention: 12,500 IU heparin s.c.
Number of subjects: 0
Study: 29843756

Group type: EXPERIMENTAL
Intervention: Liquid-based cytology
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional glass slides
Number of subjects: 10
Study: 27881082

Group type: EXPERIMENTAL
Intervention: HPV testing using the cobas 4800 HPV Test across four laboratories (three implementation laboratories and one reference laboratory)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: HPV testing for negative cytology specimens
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: HPV testing for abnormal cytology specimens
Number of subjects: 500